跳至主要内容
临床试验/IRCT20191222045853N1
IRCT20191222045853N1已完成3 期

Investigating the effect of nano-curcumin supplementation on ventilatory capacity, polmonary function indices and serum interleukin-6 of patients with stage 3 (severe) and 4 (very severe) chronic obstructive pulmonary disease

Oroumia University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 65 years(—)
性别
All

入选标准

  • Adult age range (18-65 years).
  • Smokers who have been smoking for at least 10 years.
  • Confirmation of chronic obstructive pulmonary disease according to GOLD criteria.
  • The patient has stages 3 and 4 of chronic pulmonary obstruction.

排除标准

  • Patient with gallstones
  • Infectious diseases
  • Gastrointestinal problems such as malabsorption
  • Other chronic diseases (such as cancer, kidney disease, diabetes, etc.).
  • Long-term use of corticosteroid drugs and compounds, ie, more than 10 days of corticosteroid use per year.
  • Use of any anticoagulant drugs such as heparin, aspirin, clopidogrel, dipyridamole, warfarin and ticlopidine.

研究者

发起方
Oroumia University of Medical Sciences

相似试验